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544Chest pain is the most common
chief complaint in patients ages
65 years and older and second
most common in patients ages 15
to 65 years treated in emergency
departments (EDs) in the United
States. It accounts for over 6
million ED visits and costs more
than $10 billion/year (1,2). The
standard evaluation for chest pain
diagnosis varies from ED to ED
and across regions. Recently, ED
observation or chest pain units
have been established across the
country in an attempt to homog-enize the standard evaluation for chest pain diagnosis, as they
have been shown to improve the clinical outcomes in patients
with possible acute coronary syndromes (ACS) (3). However,
only about one third of U.S. EDs currently operate obser-
vation units capable of performing timely functional testing
(4). Thus, chest pain remains a major contributing cause of
ED crowding and unnecessary hospital admissions.
Recently coronary computed tomographic angiography
(CCTA) has emerged as a useful tool for ruling out the
presence of signiﬁcant obstructive coronary artery disease
(CAD) in patients with stable symptoms (5). Additionally,
in several small-scale, single-center studies and in three
multicenter trials, CCTA was shown to be a safe and cost-
efﬁcient method of acute chest pain evaluation compared
with the commonly used functional testing (6–9). However,
these studies are limited in that CCTA availability was
constrained to weekdays and ofﬁce hours, whereas EDs are
24/7 operations. A recent prospective study showed that the
implementation of a CCTA program that runs 12 h/day on
weekdays only can safely discharge patients with negative or
nonobstructive CCTA ﬁndings using a triage protocol (10).
To date, there have been no studies evaluating effectiveness
of daily availability of CCTA for at least 12 h/day contin-
uously for chest pain triage in a busy ED. Such evaluations
must be performed to assess the effectiveness of introducing
a new diagnostic tool in clinical practice.
We have previously reported that routine CCTA in the
evaluation of low- to intermediate-risk chest pain in a
tertiary care, university-based, suburban, academic medical
center ED was feasible and safe (11). Our current observa-
tional study sought to compare the overall impact on clinical
outcomes and efﬁcacy between CCTA and our local stan-
dard evaluation for the triage of chest pain in our ED when
CCTA was available 12 h/day, 7 days/week.
Methods
We employed a retrospective, observational design, with all
data abstracted from the hospital discharge and follow-up
records. The ED, with an annual census of approximately
90,000, used the chest pain triage algorithm shown inFigure 1 before and after January 1, 2009, when routine
CCTA was introduced. Following the initial clinical assess-
ment, all chest pain patients with an admitting diagnosis of
cardiac chest pain underwent an initial 12-lead electrocardi-
ography (ECG) and blood draw for cardiac troponin I level.
Patients without ST-segment elevation, ST-segment depres-
sion of 1 mm, or positive cardiac troponin I (>0.04 pg/ml)
were assessed in the ED by standard evaluation before CCTA
introduction and by either standard evaluation or CCTA after
introduction on the basis of each ED physician’s discretion.
The study design was approved by the institutional review
board.
Patients. From January 1, 2008, to April 30, 2010, the ED
treated 9,308 patients with admitting diagnoses of chest pain
(International Classiﬁcation of Diseases-Ninth Revision-
Clinical Modiﬁcation codes 786.5X). Patients were excluded
if they presented with ACS (positive troponin I or ischemic
changes on ECG) (n ¼ 24) or noncardiac chest pain (no
ECG or cardiac biomarkers obtained during the ED visit)
(n ¼ 2,220), had a known history of CAD (n ¼ 1,772), or
were discharged to home with a length of stay in the ED
shorter than 3 h (considered too short a duration to rule out
ACS) (n ¼ 601). After exclusion, 4,691 total cases remained
in the study cohort. We then matched propensity scores for
CCTA and standard evaluation to develop a matched sample
of 894 patients for the two comparative groups (Fig. 2).
Standard evaluation. The standard evaluation included
ED cardiac monitoring, in which serial ECGs were obtained
for the detection of ischemic ECG changes, and serial blood
draws for troponin I level were taken for ruling out ACS.
Patients were discharged after evaluation in the ED or were
admitted to rule out ACS on a medical ﬂoor. Inpatient stress
testing was performed if deemed necessary by the evaluating
cardiologist. The discharge plan included a follow-up eval-
uation with cardiology and outpatient stress testing within
72 h strongly recommended.
Coronary computed tomographic angiography. On Jan-
uary 1, 2009, CCTA was introduced as a new, alternative
option for ED evaluation of non-ACS cardiac chest pain.
The attending ED physician chose between standard eval-
uation or CCTA, depending on CCTA availability and
clinical suitability. CCTA was offered from 8 AM to 8 PM
daily, including weekends and holidays. Patients with an
estimated glomerular ﬁltration rate >50 ml/min/1.73 m2 and
for whom iodinated contrast was not contraindicated were
considered for CCTA. All CCTA patients needed to be
able to cooperate and to have a body mass index (BMI)
of <50 mg/m2. Unless contraindicated, all CCTA patients
received 50 mg of oral metoprolol if the heart rate was
>60 beats/min, and 100 mg if the heart rate was >70 beats/
min, as long as the mean blood pressure was >70 mm Hg on
evaluation in the ED. Patients with active asthma for whom
beta-blockers were contraindicated were given intravenous
diltiazem 20 mg (0.25 mg/kg) over 2 min, which was
repeated, if needed, after 15 min. Unless contraindicated, all
patients received 0.4 mg of sublingual nitroglycerin about
Figure 1 Chest Pain Algorithm Before and After January 2009
The line above “After 1/2009” represents the addition of coronary computed tomographic angiography (CCTA) as an option for evaluation of low to intermediate risk chest pain.
CABG ¼ coronary artery bypass grafting; CAD ¼ coronary artery disease; ECG ¼ electrocardiography; MI ¼ myocardial infarction.
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5455 min before the contrast study. All CCTA patients were
scanned using a dedicated 64-slice CT scanner (GEVCT,
GE Healthcare, Milwaukee, Wisconsin) located in the ED.
Patients with a BMI <30 kg/m2 were scanned with 100 kV;
patients with a BMI between 30 and 50 kg/m2 were scanned
with 120 kV.
Patients with heart rates 65 beats/min were scanned pro-
spectively. For heart rates >65 beats/min but <100 beats/min,
retrospective gating with dose modulation was used. No
patients were excluded based on a high or low heart rate as
long as the cardiac rhythm was normal sinus and the heart
rate was <100 beats/min. The volume of contrast Ultravist
370 (Bayer HealthCare, Montville, New Jersey) used was
75 ml for single rule-out and 110 ml for triple rule-out
(i.e., ruling out CAD, acute aortic dissection, and acute
pulmonary embolism). All CCTA studies were evaluated
within 1 h of the scan by a level III ACC/ACR certiﬁed
imaging expert. Nonobstructive CCTA was deﬁned as <50%
maximal diameter stenosis using images from the best
cardiac phase and multiplanar reconstruction post-processing
technique in a transverse coronary section across the nar-
rowest segment compared with the nearest normal lumen.
Normal CCTA was deﬁned as 0% stenosis and 0 calcium
score. Obstructive CCTA was deﬁned as 50% stenosis
(Fig. 3). The total effective radiation dose per CCTA studywas recorded for each patient. Effective radiation dose was
derived from the summed dose-length product multiplied by
the standard conversion factor (0.014 mSv/[mGy$cm]).
Endpoints. The primary study outcome was the hospital
admission rate, deﬁned as the percentage of patients admitted
to the hospital. The secondary study outcome was length of
stay in the ED for patients discharged to home from the ED
and length of stay in the hospital for patients admitted.
Length of stay was obtained by subtracting the ofﬁcial arrival
time to the ED from the discharge time as indicated in the
hospital discharge record. Other study endpoints included
1-month follow-up and major adverse cardiovascular events
(MACEs), including death, acute myocardial infarction
(AMI), and return for pulmonary embolism; ED and
hospital recidivism rates; downstream functional testing and
invasive diagnostic and interventional procedures, that is,
invasive coronary angiography, and percutaneous and
surgical revascularization. To assess the radiation safety of
CCTA, we tabulated the total effective radiation dose of
each CCTA study.
Statistical methods. Our null hypothesis was that no
difference exists between the overall healthcare resource
utilization and outcomes in patients receiving CCTA as
opposed to standard evaluation. We assessed the demo-
graphics and medical risk of our population using
Figure 2 Study Algorithm With Results
*ECG or imaging stress test was performed in the ED prior to discharge. All patients were later sent home. Two normal CCTA had negative stress testing in the ED prior to
discharge. yPatients were referred to outpatient stress testing. zOne uncertain CCTA was later sent home following a negative stress test performed while in the ED and two had
negative stress test immediate following the ED visit. xExclusion criteria.
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546independent t tests and concluded that standard-evaluation
patients had a slightly higher clinical risk (Table 1). To
control for this difference, we used logistic regression analysis
to calculate propensity scores for receiving CCTA using the
following risk factors routinely evaluated during ED workup
as binomial variables: hypertension, hyperlipidemia, diabetes,
patient current/historical smoking status, sex, BMI, renal
status, heart failure, number of cardiac risk factors, and age
(categorized by quintile) (12). We then calculated the area
under the receiver-operating characteristic (ROC) curve to
assess the overall predictability of our model. We then
matched propensity scores for CCTA and standard evalua-
tion to develop a matched sample, using nearest-neighbor
matching that controlled for potential differences in severity
of observable cardiac disease between the two groups, using
StataPScore (software written by S. Becker and A. Ichino)
and PSMatch2 (software written by E. Leuven and B.
Sianesi). We theorized that as the time elapsed after CCTA
implementation increased, the likelihood that the EDmedical and clinical staff would use CCTA would also
increase due to increased experience, and that the staff’s
knowledge of CCTA might be inﬂuenced by their work-shift
assignments. Because these inﬂuences are not directly
observable but may be picked up by our variable of interest,
we tested for their impact by using a biprobit model.
Following our evaluation of the unobserved bias using
a biprobit model, we concluded that although unobserved
biases were present, the effects of using CCTA still existed
when we controlled for these biases. See the Online
Appendix for further discussion of the biprobit model.
We performed multivariate logistic regression to evaluate
the likelihood of being admitted and receiving downstream
invasive evaluation, adjusting for additional risk factors
including subacute ischemia, ischemia, atherosclerosis,
aneurysm, stroke, angina, circulatory disorders, peripheral
vascular disease, congestive heart failure, insurance status,
race, number of diagnoses documented, and the time
of arrival in the ED. We assessed ED length of stay
Figure 3 CCTAs in a Patient With ACS and in a Patient With Normal Coronary Arteries
(Top) Patient with ACS; (bottom) patient with normal coronary arteries. Red arrows indicate a coronary thrombus in the 2D MIP and MPR images. Blue arrows indicate a normal
coronary artery in the 2D MIP and MPR images. 2D ¼ two-dimensional; 3D VR ¼ 3-dimensional volume rendering image; ACS ¼ acute coronary syndromes; CCTA ¼ coronary
computed tomographic angiography; MIP ¼ maximum intensity projection image; MPR ¼ multiplanar reformatted image.
Table 1 Baseline Patient Demographics and Risk Factors: Unmatched and Matched Cohorts
All Patients Matched Patients Only
CCTA
(n ¼ 1,061)
Standard Evaluation
(n ¼ 3,630) p Value
CCTA
(n ¼ 894)
Standard Evaluation
(n ¼ 894) p Value
Age (%) 49  11 (47) 51  16 (50) 0.001 49  11 (48) 49  12 (47) 0.802
Male 503 (47) 1,673 (46) 0.448 430 (48) 430 (48) 1.000
Minority 196 (18) 728 (20) 0.255 158 (18) 176 (20) 0.275
Cardiovascular risk factors
No. of risk factors
Mean (median) 0.92 (1) 1.14 (1) 0.001 0.84 (1) 0.84 (1) 1.000
0 or 1 risk factor 786 (74) 2,372 (65) 0.001 690 (77) 690 (77) 1.000
2 or 3 risk factors 268 (25) 1,195 (33) 0.001 200 (22) 200 (22) 1.000
4 risk factors 7 (1) 63 (2) 0.011 4 (<1) 4 (<1) 1.000
Major risk factors (ICD code)
Hypertension (401.XX to 405.XX) 355 (33) 1,506 (41) 0.001 294 (33) 294 (33) 1.000
Smoking (305.1, V15.82) 335 (32) 1,190 (33) 0.460 257 (29) 257 (29) 1.000
Dyslipidemia (472.XX) 186 (18) 957 (26) 0.001 141 (16) 141 (16) 1.000
Family history CAD (V17.3, V17.4) 121 (11) 392 (11) 0.578 103 (12) 118 (13) 0.316
Diabetes (249.XX–250.XX) 97 (9) 508 (14) 0.001 56 (6) 56 (6) 1.000
Other risk factors
Underweight (BMI <18.5 kg/m2) 9 (1) 83 (2) 0.006 7 (1) 7 (1) 1.000
Healthy weight (BMI 18.5–24.9 kg/m2) 211 (22) 913 (26) 0.011 188 (21) 188 (21) 1.000
Overweight (BMI 25–29.9 kg/m2) 374 (39) 1,211 (34) 0.009 354 (40) 354 (40) 1.000
Obesity (BMI 30–39.9 kg/m2) 297 (31) 1,050 (30) 0.511 279 (31) 279 (31) 1.000
Morbid obesity (BMI >40 kg/m2) 78 (8) 295 (8) 0.798 66 (7) 66 (7) 1.000
Renal failure (eGFR 15) 3 (<1) 85 (2) 0.001 1 (<1) 1 (<1) 1.000
Severe kidney disease (eGFR >15–30) 0 67 (2) 0.001 0 0
Circulatory disease (ICD code 459.89) 121 (11) 392 (11) 0.578 104 (12) 118 (13) 0.316
Stroke (ICD code 430.XX–438.XX) 3 (<1) 53 (1) 0.002 3 (<1) 11 (1) 0.032
Peripheral vascular disease (ICD code 443.XX) 2 (<1) 43 (1) 0.003 2 (<1) 6 (1) 0.157
Values are mean  SD (%) or n (%).
BMI ¼ body mass index; CAD ¼ coronary artery disease; CCTA ¼ cardiac computed tomographic angiography; eGFR ¼ estimated glomerular ﬁltration rate; ICD ¼ International Classiﬁcation of Diseases.
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Table 2
Study Endpoints in Matched Patients: Admission
Rate, Length of Stay, MACE, Additional Patient
Follow-Up, and Downstream Resource Utilization With
CCTA Versus Standard Evaluation (Both, n ¼ 894)
CCTA
Standard
Evaluation p Value
Admission rate 123 (14) 358 (40) 0.001
Length of stay, mean (median)
Admitted from ED, days 2.7 (2) 2.5 (2) 0.622
Discharged from ED chest pain
peak hours*
7.7 (6.5) 11.5 (7.4) 0.001
MACE at 1 month
Acute myocardial infarction 3 (<1) 6 (1) 0.316
Death 0 0
Additional patient follow-up
Reason for return to ED
Cardiac reason (excluding
chest pain)
7 (1) 12 (1) 0.249
Chest pain 5 (1) 20 (2) 0.003
Pulmonary embolism 2 (<1) 6 (1) 0.157
Activity after testing in ED
Discharged 7 (1) 17 (2) 0.040
Admitted 5 (1) 15 (2) 0.025
Downstream resource utilization
Stress test 33 (4) 184 (21) 0.001
Treadmill stress test 25 (3) 82 (9) 0.001
Revascularization
(PCI and CABG)
23 (3) 19 (2) 0.533
Invasive coronary
angiography only
8 (1) 27 (3) 0.001
Nuclear stress test 8 (1) 102 (11) 0.001
Values are n (%). *From matched groups of patients (n ¼ 432).
CABG ¼ coronary artery bypass grafting; CCTA ¼ cardiac computed tomographic angiography;
ED ¼ emergency department; MACE ¼ major adverse cardiovascular event(s); PCI ¼ percutaneous
coronary intervention.
Table 3
ORs of Study Endpoints: Standard Evaluation Versus
CCTA (Both, n ¼ 894)
OR CI p Value
Admission rate 5.53 3.8–8.0 0.001
Length of stay, mean (median)
Admitted from ED, days 1.11 1.0–1.3 0.184
Discharged from ED chest pain peak
hours
1.55 1.21–1.98 0.001
MACE at 1 month
Acute myocardial infarction 4.26 0.3–71.4 0.313
Additional patient follow-up
Reason for return to ED
Pulmonary embolism 9.23 0.8–100.5 0.068
Cardiac reason (excluding
chest pain)
2.39 0.7–8.5 0.178
Chest Pain 5.06 1.3–20.3 0.022
Activity after testing in ED
Admitted 2.29 0.6–8.5 0.214
Discharged 4.76 1.2–18.9 0.026
Downstream resource utilization
Stress test 6.13 3.8–9.8 0.001
Treadmill stress test 4.78 2.8–8.3 <0.0001
Nuclear stress test 7.05 3.1–15.9 <0.0001
Invasive coronary angiography only 7.17 2.5–20.6 <0.0001
Revascularization (PCI and CABG) 2.06 0.7–6.11 0.193
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Table 2.
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548using the maximum likelihood survival analysis, inverse
Gaussian frailty model. Stata version 10.1 (StataCorp,
College Station, Texas) was used for all data analyses.
Results
Overall study endpoints. Figure 2 presents the study
algorithm, showing each decision point and outcomes in the
ED evaluation process. Our propensity score model pro-
vided only moderate predictive power in distinguishing
CCTA and standard evaluation (ROC: 0.67). The results of
the study endpoints using an independent t test comparison
on our matched sample of standard evaluation and CCTA
are presented in Table 2. Additionally, multivariate logistic
analysis results, used to make further risk adjustments, are
presented in Table 3.
Primary study endpoint. OVERALL HOSPITAL ADMISSION
RATES. Admission rates for standard evaluation and CCTA
were 40% and 14%, respectively (p < 0.0001). In our logistic
analysis, the likelihood of being admitted was signiﬁcantly
greater in standard-evaluation patients and increased over
time (all years, OR: 5.53 [95% CI: 3.8 to 8.0; p < 0.001];
for 2009, OR: 3.98 [95% CI: 2.5 to 6.3; p < 0.001]; for
2010, OR: 9.3 [95% CI: 4.7 to 18.5; p < 0.001]).Secondary endpoint. LENGTH OF STAY. We examined
length of stay in patients discharged from the ED with
a primary diagnosis of chest pain. In evaluating ED length
of stay, we began with examining the change for the entire
population before and after implementation of CCTA. The
length of stay in the ED fell over the course of our study,
from January 2008 to April 2010. However, the length of
stay in patients arriving between 8 AM and 12 PM was not
signiﬁcantly shorter (OR: 1.29; 95% CI: 0.79 to 2.10; p ¼
0.298). CCTA had the most signiﬁcant impact on length of
stay during the time period when the ED operated at peak
volume and CCTA was open (from 12 PM to 8 AM daily).
The expected length of stay in the ED was 1.6 times higher
with standard evaluation (OR: 1.55; 95% CI: 1.2 to 2.04;
p < 0.001) (Table 3). Of the matched CCTA group, only
185 CCTA patients were evaluated when CCTA was
closed, that is, from 8 PM to 8 AM. The mean length of ED
stay in the CCTA group was signiﬁcantly shorter than in the
standard-evaluation group (7.7 vs. 11.5 h). Figure 4 shows
the cumulative distribution of patients remaining with
length of stay data in the 2 groups of 432 cases each.
Seventy-ﬁve percent of CCTA patients were expected to be
discharged within 8 h compared with 14 h with standard
evaluation.
Other endpoints. MACE OUTCOMES. DEATHWITHIN 30 DAYS.
We examined our medical center records and the Social
Security Death Master File. There were no cardiac deaths in
either group.
AMI WITHIN 30 DAYS. We then evaluated the likelihood of
experiencing an AMI from the time of the initial ED visit to
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Matched cohorts of 432 cases each. Abbreviations as in Figure 2.
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549within 30 days of the index visit. Six patients (1%) in the
standard-evaluation group and 3 patients (<1%) in the
CCTA group had AMI (p ¼ 0.316). All AMIs occurred
during the index visit. Of the 3 patients who had CCTA
and AMI, all had AMI on admission. One patient had
obstructive CCTA and the other 2 were nondiagnostic.
Both patients with nondiagnostic CCTA had normal levels
of initial cardiac biomarkers, and one was post intervention.
Similarly, all 6 standard-evaluation cases had AMI during
the index visit. Five had elevated levels of second or third
cardiac biomarkers. One had a positive level post interven-
tion. The risk for experiencing AMI was not signiﬁcantly
different between the standard-evaluation and CCTA
cohorts (OR: 4.26; 95% CI: 0.3 to 71.4; p ¼ 0.313).
ED OR HOSPITAL RECIDIVISM RATE. We reviewed the number
of patients who returned to the hospital within 30 days of
the index admission: 3.6% of standard-evaluation patients
returned compared with 1.3% of CCTA patients (p ¼ 0.002).
However, the likelihood of returning after complete risk
adjustment was not signiﬁcantly different between the two
groups (OR: 8.53; 95% CI: 0.4 to 179.9; p ¼ 0.168). We also
explored reasons for return, including admission for pulmo-
nary embolism, cardiac reasons (ICD-9 codes 390.** to 459.**)
excluding chest pain, and chest pain alone (Table 2). We
found no signiﬁcant differences in the likelihood of returning
for cardiac reasons (OR: 2.30; p ¼ 0.178) or for pulmonary
embolism (OR: 9.23; p ¼ 0.068). However, for chest pain
alone, the likelihood of returning was signiﬁcantly greater in
the standard-evaluation patients (OR: 5.066; p ¼ 0.022).
DOWNSTREAM RESOURCE UTILIZATION OF DIAGNOSTIC
PROCEDURES AND INTERVENTIONS. STRESS TESTING. When
patients were discharged from the ED after ACS rule-out,
they were instructed to contact a cardiologist for possible
stress testing within 72 h. We could validate only that 754patients (21%) in the full standard-evaluation cohort
received stress testing. Among admitted inpatients, 36.9% of
standard-evaluation patients and 24.8% of CCTA patients
had stress testing. Among discharged outpatients, 9.9% of
standard-evaluation patients and 0.3% of CCTA patients
had stress testing. The majority of the stress testing per-
formed involved single-photon emission computed tomog-
raphy, with which the total radiation dose for our typical
1-day stress–rest protocol was 12 mSv (3.5 mSv for rest
and 8.5 mSv stress). Stress tests following CCTA were
mainly used to determine the functional signiﬁcance of
nondiagnostic or obstructive CCTA results.
INVASIVE CORONARY ANGIOGRAPHY. Standard-evaluation
patients were signiﬁcantly more likely to receive invasive
coronary angiography without subsequent revascularization
(27 [3%] vs. 8 [1%]; p < 0.001). When risk-adjusted, the
likelihood of standard-evaluation patients having invasive
coronary angiography without subsequent revascularization
was 7 times higher (OR: 7.17; 95%CI: 2.5 to 20.6; p< 0.001;
Tables 2 and 3).
CORONARY REVASCULARIZATION (PERCUTANEOUS CORONARY
INTERVENTION OR CORONARY ARTERY BYPASS GRAFTING). The
difference in revascularization rates between CCTA and
standard evaluation was not signiﬁcant (23 [3%] vs. 19 [2%],
respectively; p ¼ 0.533]. The difference in the likelihood of
standard-evaluation and CCTA patients undergoing coro-
nary revascularization was not signiﬁcant (OR: 2.06; 95%
CI: 0.7 to 6.11; p ¼ 0.193). No patients who had normal or
nonobstructive CCTAs received invasive coronary angiog-
raphy or coronary intervention.
CCTA-ASSOCIATED RADIATION DOSE. After excluding pa-
tients who received additional noncardiac CT scanning
on the same occasion of service and those with missing
radiation-dose data (n ¼ 22 [2%]), 1,039 patients remained.
Nearly 32% of the CCTAs done were for triple rule-out.
These cases typically carry exposure rates nearly 50%
higher than those of cases ruling out CAD only (13). Our
median radiation dose was 5.88 mSv (95% CI: 5.2 to 6.4)d
16.22 mSv (95% CI: 15.0 to 17.4) for retrospective scans
(n ¼ 432 [42%]) and 3.61 mSv (95% CI: 3.4 to 3.8) for
prospective scans (n ¼ 605 [58%]).
Discussion
We believe this is the largest single-center observational
study to date comparing the routine use of CCTA to
a standard-evaluation approach. Many EDs in the United
States follow similar protocol for standard evaluation, in
which most chest pain patients are discharged after serial sets
of cardiac biomarkers and nondiagnostic ECGs (14).
The results of the primary endpoints on hospital admission
rate and length of stay in the ED support those from the three
completed randomized controlled trials to date: CCTA
reduced unnecessary hospital admissions and ED length of
stay (6,8,9). The current study adds to the literature as its
retrospective, observational design begins to validate that these
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550savings are possible in clinical practice. It addresses potential
investigational bias resulting from experimental controls that
cannot exist in an ED environment and may, therefore, render
accurate efﬁciency analysis impossible. For example, the
published randomized controlled trials used CCTA during
business hours and weekdays only. This is not a reasonable
expectation for a busy ED. Throughout our study, CCTA was
continuously available for 12 h/day. As our implementation of
CCTA progressed, ED physicians and clinical staff became
more comfortable with, and aware of the advantages of, using
CCTA, which resulted in a signiﬁcant improvement in the
OR for the overall hospital admission rates, from 3.98 in 2009
to 9.2 in 2010. The length-of-stay analysis was not biased by
research protocols with dedicated personnel to conduct the
study, yielding a truer assessment of how CCTA affects length
of stay in clinical practice.
Many EDs in the United States consistently experience
crowding that challenges providers’ capability of efﬁciently
caring for patients. A recent study documented that this
crowding causes inefﬁciencies and can result in higher death
rates (15). Additionally, it has been shown that ED crowding
may be associated with post-traumatic stress disorder in
patients who presented to the ED with ACS (16). The
average length of stay in the ED, when inpatient treatment
was not indicated, was 8.5 h. The potential savings of 2 to 3 h
per patient through the use of CCTA was associated with no
reduction in the quality of outcomes. This work is important
because reducing extended ED stays contributes to improve-
ment in overall quality and cost efﬁciency.
In our cohort of low-risk patients, we could document
follow-up stress testing within 1 month in only 21% of
standard-evaluation patients. Some patients may have left
our network for follow-up, and that information may not
have been available to us. This low stress-testing rate in the
standard-evaluation patients was not unexpected, because
only about one-third of EDs are equipped to perform
stress testing, and signiﬁcantly fewer are capable of timely
management of the large volume of chest pain patients
encountered each day (4). Accordingly, many patients are
discharged without provocative testing or remain in the ED
or hospital for observation for 10 h or more. A scientiﬁc
statement from the American Heart Association on the
testing of low-risk patients with chest pain in the ED
recognizes the value of outpatient exercise stress testing
within 72 h of the ED visit, as many hospitals lack the
resources to properly complete inpatient stress testing (17).
However, a recent study found that only 36% of patients
referred to outpatient stress tests actually completed them,
increasing patients’ risk for subsequent ED visits and
the potential for missed ACS (18). Because many EDs
are limited in the ability to provide long-term follow-up
of low-risk ACS patients, the longer-term risk to
these patients is not fully understood and warrants further
research.
When patients are admitted for chest pain, one of the
most resource-intensive diagnostic procedures performed isinvasive coronary angiography (19). As CCTA provides
accurate diagnostic information concerning coronary
obstruction, patients in the standard-evaluation cohort
were 7 times more likely to have an invasive coronary
angiography without subsequent revascularization. This is
in sharp contrast to the ﬁndings in the recently published
SPARC (Study of Myocardial Perfusion and Coronary
Anatomy Imaging Roles in Coronary Artery Disease), in
which invasive coronary angiography was more frequent
after CCTA (20). This difference in invasive coronary
angiography use was most likely due to differences in
patient selection and use of stress testing. The current
study consisted of mostly low-risk chest pain patients,
whereas the SPARC patients were of intermediate to high
risk. Additionally, because many hospitals across the
country are not equipped to perform routine stress testing
in the ED, physicians may rely on invasive coronary
angiography as a primary diagnostic test in higher-risk
patients. Our results demonstrate that signiﬁcantly more
potentially avoidable invasive coronary angiography
procedures are performed after standard evaluation
compared with CCTA. This results in increased risks
related to invasive procedures and radiation exposure
(21). The recently published ROMICAT-II (Rule Out
Myocardial Infarction using Computer Assisted Tomog-
raphy) trial (7) showed a higher rate of downstream
invasive testing after CCTA compared with standard
evaluation (11% vs. 7%, respectively). However, the
standard-evaluation group in that trial had a functional
testing rate of 78%da rate that is not achievable in most
U.S. EDs; therefore, the results for downstream testing
rates in the studies are not comparable.
Controversy remains as to whether any testing is war-
ranted in such low-risk patients following negative initial
ECG and cardiac biomarkers because both CCTA and
nuclear stress testing increase the risk for cancer due to
radiation exposure. Our study in low-risk patients contained
a total combined revascularization and AMI rate of 2.4%
(95% CI: 1.6% to 3.7%). Applying this rate of risk for
adverse incident to the general population of 6 million
patients per year implies that doing nothing would place
144,000 patients annually at risk for inadequate care with
serious outcomes. At an average age of 49 years, these
patients would experience permanent detriment to quality of
life and economic production. Yet, caring for emergent, low-
risk acute chest pain patients represents a high cost to the
system resulting from patient volume and diagnostic chal-
lenges. We estimated that ED chest pain patients receiving
standard evaluation were 5.5 times more likely to be
admitted. We have presented substantial evidence that
CCTA improves the efﬁciency of triaging chest pain
patients in the ED.
CCTA has been criticized for placing patients at
increased risk for radiation exposure. In the ROMICAT-II
trial (7), cumulative exposures were 13.9 mSv with CCTA
and 4.7 mSv with standard evaluation. In the CT-STAT
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Systematic Triage of Acute Chest Pain Patients to
Treatment) trial (6), the reported median radiation dose in
the arm that received CCTA with 64-slice CT scanner
technology was 12.8 mSv. Our patients’ exposure levels
were substantially lower (22,23). The median radiation
exposure was 5.89 mSv, despite a 32% triple rule-out rate.
Using our current pre-medication protocol of adminis-
tering an oral beta-blocker 1 h prior to scanning, 58% of
the patients achieved heart rate control adequate for pro-
spective scanning. The mean effective radiation dose
exposure with this dose-saving scanning technique was
3.62 mSv.
Study limitations. Although a retrospective and observa-
tional study design has limitations, it allows a fuller assess-
ment of the in-practice value of introducing a new diagnostic
modality in a busy clinical environment, now that safety has
been conﬁrmed. Observational studies always carry risk
related to selection bias; however, we found our analytic
results to be consistent and rigorous to many variations in
methodology. The lack of availability of CCTA from 8 PM
and 8 AM was a limitation of the CCTA arm, but the
incremental cost to perform CCTA around the clock is
extremely high and probably not medically necessary, as all
CCTA patients had negative initial cardiac biomarkers and
ECG for ACS and most of these patients had normal or
nonobstructive CCTA. Patients who came to the ED when
CCTA was not available were either kept in the ED or
admitted to the medical ﬂoor for further observation. In
addition, our propensity model did not demonstrate a strong
relationship between key medical history/conditions and the
use of CCTA as a diagnostic tool (ROC: 0.67). We believe
this was a result of the availability of CCTA over the course
of the day and of the gradual increase in the adoption of
CCTA by our staff. Our local standard evaluation lacks
adequate resources to perform timely ED stress testing,
which partially drives the superior results of our CCTA
program. Nonetheless, our standard-evaluation practice
represents the norm for many U.S. EDs that lack resources
to perform timely stress testing. Additional evaluations will
be necessary to conﬁrm these results; however, as knowledge
and capabilities of the use of CCTA progress, this tech-
nology may offer an alternative means of improving services
for chest pain patients.Conclusions
Implementation of a protocol for ruling out ACS in low-risk
chest pain patients using CCTA will likely increase emer-
gency physicians’ ability to accurately and efﬁciently triage
patients with this common presenting symptom. This may
result in a reduced need for inpatient admissions, ED length
of stay, chest pain recidivism rate, and downstream evalua-
tion by invasive coronary angiography, and may enhance
treatment efﬁcacy.Acknowledgments
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APPENDIX
For more details on the methods of this study and supplemental tables,
please see the online version of this article.
